Published October 29, 2024
| Version v1
Other
Open
Effectiveness of COVID-19 vaccines against severe acute respiratory infections hospitalization associated with laboratory-confirmed SARS-CoV-2 over a two period in Ghana
Creators
- Amoako, Nicholas (Researcher)
- Cohuet, Sandra (Researcher)
- Rockson, Michael (Researcher)
- Gurry, Celine (Researcher)
- Oduro, Abraham (Researcher)
- Agyapong, Prince (Researcher)
- Musah, Osei (Researcher)
- Asantewaa, Ivy Asante (Researcher)
- Mensah, Anthony Affum (Researcher)
- Djanie, , Reuben Ayivor (Researcher)
- Duedu, Kwabena (Researcher)
- Kenu, Ernest (Researcher)
- Adjei, George Obeng (Researcher)
- Dabo, Ellis Owusu (Researcher)
- Amuasi, John (Researcher)
- Asiedu-Bekoe, Franklin (Researcher)
- Laryea, Dennis (Researcher)
- Kasolo, Francis (Researcher)
- Ohene, Sally-Ann (Researcher)
- Rose, Angie (Researcher)
- Nardone, Anthony (Researcher)
- Archibald, Worwui Kwame (Researcher)
- Humphreys, James (Researcher)
- Ampofo, William (Researcher)
- Owusu-Agyei, Seth (Researcher)
- Mwenda, Jason (Researcher)
- Asante, Kwaku Poku (Researcher)
Description
The use of vaccines to respond to the COVID-19 pandemic required vaccine effectiveness monitoring in the context of new viral variants and changing epidemiology. This study measured COVID-19 vaccine effectiveness (VE) against laboratory- confirmed SARS-CoV-2 in hospitalized patients diagnosed with severe acute respiratory infections (SARI).
Files
UHASRC202415085-1 (1).pdf
Files
(40.6 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:ead72be2cdec615431f13106c1e70838
|
40.6 kB | Preview Download |
Additional details
Dates
- Accepted
-
2024-10-29University of Health and Allied Sciences